Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
MRNA

Moderna, Inc. (MRNA)

NASDAQ
$196.74
-$10.78
(-5.21%)
Previous Close: ⁦$206.80⁩
Market Closed

Last updated: ⁦2026-11-19 02:28:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Moderna, Inc. (MRNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $196.74, with a market capitalization of $87.10B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $22.28 to $280.80. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$87.10B

$206.80

$209.56

$196.58

$206.80

6.02M

19.35M

--

$280.80

$22.28

--

2026-09-30

Moderna, Inc. (MRNA) Latest Closing Stock Price

Moderna, Inc. (MRNA) last closed at $196.74 as of 2026-11-19 01:00:00, down 5.21% ($10.78) from the previous close of $206.80.

During the latest regular trading session, MRNA traded between $196.58 and $209.56, with a volume of 6.02M shares. The closing price was near the lower end and near the upper end of its 52-week range.

Moderna, Inc. (MRNA) 7-Day Stock Price Change

Over the past seven days, Moderna, Inc. (MRNA) moved from $269.00 to $196.74, representing a decline of 26.86% ($72.26).

The stock traded between $196.58 and $280.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 8.79 million shares, down versus the previous seven-day period, indicating lower trading activity.

MRNA 52-Week Price Position

Position in Range: 67.5%

52W Low$22.28
52W High$280.80

MRNA is currently trading at $196.74, placing it 67.5% of the way from its 52-week low of $22.28 to its 52-week high of $280.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Moderna, Inc. (MRNA)?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna, Inc. Information

Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
4,700
CEO
Stéphane Bancel
Founded
2010
Exchange
NASDAQ
Company Website

MRNA News

Latest news related to Moderna, Inc. and MRNA stock.

  • Massive

    NSCLC Treatment Landscape Shifts as ESMO 2026 Spotlights MET, KRAS, and TROP2 Advances, Says DelveInsight

    The non-small cell lung cancer market is shifting toward precision, biomarker-guided treatment sequencing. ESMO 2026 presented Phase III data showing savolitinib plus osimertinib improved survival in MET-altered EGFR-mutated NSCLC, divarasib outperformed approved KRAS G12C inhibitors, and TROP2-directed ADCs demonstrated durable gains. The 7MM NSCLC market is projected to double from USD 33 billion in 2025 to USD 67 billion by 2036, driven by expanded screening, biomarker-driven therapies, and label expansions into earlier-stage disease.

    Read Full Article
  • Massive

    Should You Really Buy Anthropic Stock At the IPO? History Has a Clear Answer for Investors.

    Anthropic is set to go public on November 19, 2026, at a $1.33 trillion valuation with a proposed IPO price of $70-$78 per share. While the company shows explosive revenue growth (12-fold increase to $17B in Q3), its 38x price-to-sales valuation is expensive. Historical data shows the 10 largest U.S. IPOs since 2006 declined an average of 32% from their IPO price within the first year, suggesting investors should wait for better entry points rather than buying at the IPO.

    Read Full Article
  • Benzinga

    JP Morgan Maintains Underweight on Moderna, Raises Price Target to $102

    JP Morgan analyst Jessica Fye maintains Moderna (NASDAQ:MRNA) with a Underweight and raises the price target from $77 to $102.

    Read Full Article
  • Massive

    Cancer Vaccines Clinical Trial Pipeline Boom as 200+ Companies are in the Race for Better Treatments | DelveInsight

    Over 200 companies are advancing cancer vaccine development with 200+ pipeline candidates in clinical trials. Recent positive Phase III results for intismeran autogene (mRNA-4157) in melanoma and encouraging data for TG4050 in head and neck cancer are driving momentum. However, challenges including clinical efficacy uncertainties, manufacturing complexity, high production costs, and patient selection barriers remain obstacles to broader commercialization.

    Read Full Article
  • Benzinga

    Live On CNBC, Josh Brown Hosts Segment Titled “Josh’s Best Stocks Update: Moderna”

    Read Full Article

Ways to Trade MRNA at MEXC

MRNA MEXC RealStocks

Own real MRNA shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

MRNA Tokenized Stocks

Get MRNA price exposure through a blockchain-based token.


Suitable for trading outside U.S. market hours.

  • Token tracks the MRNA price
  • Trade 24/7
  • Trade on weekends and holidays

MRNA Stock Futures

Trade MRNA price movements with futures contracts.


Suitable for short-term positions.

  • Go long or short
  • Trade 24/7
  • Up to 20x leverage

How to Buy Moderna, Inc. (MRNA) Stock on MEXC

Eligible investors can buy real shares of Moderna, Inc. (MRNA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for MRNA and Place Your Order
Step 3: Search for MRNA and Place Your Order
Open the RealStocks trading page and search for MRNA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Moderna, Inc. (MRNA) stock price today?
Moderna, Inc. (MRNA) is currently trading at $196.74, down 5.21% ($10.78) from the previous close of $206.80. Intraday prices update in real time during regular trading hours.
2.Is MRNA stock going up or down today?
As of 2026-11-19 01:00:00, MRNA is trading at $196.74, down 5.21% ($10.78) from its previous close of $206.80. The stock has traded between $196.58 and $209.56 during today’s regular session. Past price movements do not guarantee future results.
3.What is MRNA pre-market price?
As of 2026-11-19 01:00:00, MRNA is trading at $204.81 in pre-market trading, down 0.96% ($1.99) from the previous close of $206.80. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is MRNA after-hours price?
As of 2026-11-19 01:00:00, MRNA is trading at $195.50 in after-hours trading, down 0.63% ($1.24) from the regular-session close of $196.74. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is MRNA stock trading now?
MRNA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does MRNA sit relative to its 52-week high and low?
Over the past 52 weeks, MRNA has traded between a low of $22.28 and a high of $280.80. At $196.74, the stock is positioned 67.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Moderna, Inc. in?
Moderna, Inc. (MRNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Moderna, Inc.'s market capitalization and where is it listed?
Moderna, Inc. is listed on the NASDAQ exchange with a market capitalization of $87.10B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is MRNA valued in terms of P/E ratio and EPS?
MRNA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-6.89. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Moderna, Inc. pay a dividend?
Moderna, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Moderna, Inc.

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MRNA, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

MRNA Stock Calculator

Estimate the value between MRNA shares and USD.

MRNA Shares to USD

MRNA Shares
MRNA
MRNA
USD
USD
USD

1.00 MRNA shares = 196.741 USD

Calculations are estimates based on the latest available price and are for reference only.